ARGENT BIOPHARMA LIMITED - Announcements

Market Cap $16.98M Add to my watchlist

Argent BioPharma Ltd, formerly MGC Pharmaceuticals Ltd, is an Australia-based drug... Argent BioPharma Ltd, formerly MGC Pharmaceuticals Ltd, is an Australia-based drug discovery company. The Company is focused on developing and supplying accessible and ethically produced plant-derived medicines, combining in-house research with technologies. Its approach combines in-house research with technology, all discovering and producing treatments for unmet medical conditions. Its investigational medicinal (IMPs) products include CannEpil, CimetrA and CogniCann. CimetrA is a phyto medicine based on natural ingredients from Curcumin and Boswellia serrata, delivered in the nanoparticle delivery system, which is being developed for acute lung injury and acute respiratory distress syndrome (ARDS). CannEpil is a phyto medicine based on phytocannabinoid is being developed for the treatment of refractory epilepsy and cerebral palsy. CogniCann is a phyto medicine based on phytocannabinoids is in investigation stage as a treatment for the symptoms associated with dementia and Alzheimer.More

Announcements

Filter Results

All Price Sensitive Only

RGT	RGT Commences Trading on the OTCQB Venture Market		07/05/24	177.59KB	Share
RGT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/04/24	448.09KB	Share
RGT	Notification regarding unquoted securities - RGT		26/04/24	16.8KB	Share
RGT	Notification of cessation of securities - RGT		15/04/24	13.72KB	Share
RGT	Argent BioPharma Appoints Dr Shlomo Sadoun to Advisory Board		15/04/24	156.12KB	Share
RGT	Change of Company Name		02/04/24	190.13KB	Share
RGT	s708A Cleansing Notice		28/03/24	216.29KB	Share
RGT	Application for quotation of securities - MXC		28/03/24	15.72KB	Share
RGT	Change of Director's Interest Notice - LM		28/03/24	178.63KB	Share
RGT	Change of Director's Interest Notice - DR		28/03/24	174.6KB	Share
RGT	Notification regarding unquoted securities - MXC		28/03/24	19.27KB	Share
RGT	Refinancing of Convertible Security Agreement		28/03/24	225.34KB	Share
RGT	Results of Meeting		18/03/24	465.62KB	Share
RGT	Half Year Accounts	PRICE SENSITIVE	29/02/24	1.01MB	Share
RGT	Notice of General Meeting/Proxy Form		13/02/24	837.82KB	Share
RGT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/24	485.92KB	Share
RGT	Notification regarding unquoted securities - MXC		19/01/24	25.15KB	Share
RGT	s708A Cleansing Notice		10/01/24	215.49KB	Share
RGT	Notification regarding unquoted securities - MXC		10/01/24	28.2KB	Share
RGT	Notification regarding unquoted securities - MXC		10/01/24	23.77KB	Share
RGT	Application for quotation of securities - MXC		10/01/24	24.85KB	Share
RGT	Application for quotation of securities - MXC		10/01/24	25.73KB	Share
RGT	Application for quotation of securities - MXC		10/01/24	25.27KB	Share
RGT	Proposed issue of securities - MXC		22/12/23	28.25KB	Share
RGT	Company Update & Capital Raising	PRICE SENSITIVE	22/12/23	252.55KB	Share
RGT	Retraction of Statement	PRICE SENSITIVE	21/12/23	198.15KB	Share
RGT	Pause in trading	PRICE SENSITIVE	21/12/23	116.81KB	Share
RGT	ArtemiC Receives FDA Approval in Saudi Arabia		19/12/23	239.8KB	Share
RGT	MGC Pharma Non-Deal Roadshow Presentation December 2023		18/12/23	2.63MB	Share
RGT	s708A(5)(e) Cleansing Notice		01/12/23	219.35KB	Share
RGT	Application for quotation of securities - MXC		01/12/23	28.96KB	Share
RGT	Notification regarding unquoted securities - MXC		01/12/23	28.87KB	Share
RGT	Initial Director's Interest Notice		01/12/23	195.37KB	Share
RGT	Final Director's Interest Notice x 2		01/12/23	413.44KB	Share
RGT	Corporate Update - Board and UK Adviser Changes		01/12/23	207.1KB	Share
RGT	Results of Meeting		30/11/23	490.44KB	Share
RGT	Change in substantial holding		09/11/23	24.76KB	Share
RGT	Capital Consolidation and US$7.9m Placement Completed		08/11/23	215.15KB	Share
RGT	s708A(5)(e) Cleansing Notice		07/11/23	219.19KB	Share
RGT	Notification regarding unquoted securities - MXC		07/11/23	28.39KB	Share
RGT	Application for quotation of securities - MXC		07/11/23	24.81KB	Share
RGT	Proposed issue of securities - MXC		01/11/23	28.95KB	Share
RGT	MGC Secures US$7.9 Million in Firm Commitments	PRICE SENSITIVE	01/11/23	270.27KB	Share
RGT	Notice of Annual General Meeting/Proxy Form		31/10/23	1.09MB	Share
RGT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/10/23	581.83KB	Share
RGT	Trading Halt	PRICE SENSITIVE	30/10/23	581KB	Share
RGT	Results of Meeting		25/10/23	485.05KB	Share
RGT	Consolidation/Split - MXC		24/10/23	31.62KB	Share
RGT	Annual General Meeting Update		09/10/23	199.6KB	Share
RGT	Appendix 4G and Corporate Governance Statement		29/09/23	653.76KB	Share
RGT	Annual Report to shareholders		29/09/23	3.14MB	Share
RGT	Managing Director's Letter to Shareholders		26/09/23	249.08KB	Share
RGT	Notice of General Meeting/Proxy Form		26/09/23	782.91KB	Share
RGT	Change in substantial holding		08/09/23	53.13KB	Share
RGT	s708A(5)(e) Cleansing Notice		06/09/23	218.72KB	Share
RGT	Application for quotation of securities - MXC		06/09/23	25.61KB	Share
RGT	Application for quotation of securities - MXC		06/09/23	25.22KB	Share
RGT	Notification regarding unquoted securities - MXC		06/09/23	28.4KB	Share
RGT	Results of Meeting		05/09/23	261.04KB	Share
RGT	Change of Share Registry Address		01/09/23	202.3KB	Share
RGT	Notification of cessation of securities - MXC		01/09/23	21.69KB	Share
RGT	Application for quotation of securities - MXC		01/09/23	24.87KB	Share
RGT	Preliminary Final Report	PRICE SENSITIVE	31/08/23	642.18KB	Share
RGT	Share Purchase Plan Closed	PRICE SENSITIVE	30/08/23	227.06KB	Share
RGT	Update - Proposed issue of securities - MXC		15/08/23	32.25KB	Share
RGT	Extension of Share Purchase Plan Closing Date		15/08/23	210.23KB	Share
RGT	Pre-clinical Trial Results on CimetrA	PRICE SENSITIVE	14/08/23	279.17KB	Share
RGT	Notice of General Meeting/Proxy Form		04/08/23	882.63KB	Share
RGT	Prospectus and Share Purchase Plan Documents		03/08/23	631.1KB	Share
RGT	Company Update		02/08/23	210.1KB	Share
RGT	Proposed issue of securities - MXC		01/08/23	32.63KB	Share
RGT	MGC Pharma Launches Share Purchase Plan	PRICE SENSITIVE	01/08/23	218.64KB	Share
RGT	MGC receives permission for first import of Psilocybin	PRICE SENSITIVE	31/07/23	256.18KB	Share
RGT	Resignation of Joint Company Secretary		28/07/23	206.96KB	Share
RGT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/07/23	782.69KB	Share
RGT	Clarification Announcement		21/07/23	252.3KB	Share
RGT	Change in substantial holding		19/07/23	183.92KB	Share
RGT	s708A(5)(e) Cleansing Notice		14/07/23	275.41KB	Share
RGT	Notification regarding unquoted securities - MXC		14/07/23	29.13KB	Share
RGT	Application for quotation of securities - MXC		14/07/23	26.78KB	Share
RGT	Update - Proposed issue of securities - MXC		14/07/23	29.25KB	Share
RGT	Proposed issue of securities - MXC		14/07/23	24.95KB	Share
RGT	Proposed issue of securities - MXC		14/07/23	29.44KB	Share
RGT	Commitments Received for GBP 0.7m	PRICE SENSITIVE	14/07/23	482.3KB	Share
RGT	Clarification Announcement		12/07/23	218.93KB	Share
RGT	AMC Places Second Order of ArtemiC for US$1M	PRICE SENSITIVE	07/07/23	242.11KB	Share
RGT	MGC Welcomes Reclassification of Psychedelic Compounds		03/07/23	194.7KB	Share
RGT	Details of Company Address		30/06/23	222.41KB	Share
RGT	Company Update		30/06/23	208.34KB	Share
RGT	Results of Meeting		29/06/23	464.39KB	Share
RGT	s708A(5)(e) Cleansing Notice		21/06/23	228.64KB	Share
RGT	Application for quotation of securities - MXC		21/06/23	25.09KB	Share
RGT	Final Director's Interest Notice x 2		01/06/23	432.88KB	Share
RGT	Initial Director's Interest Notice		01/06/23	198.4KB	Share
RGT	Appointment of Non-Executive Director		01/06/23	211.57KB	Share
RGT	First CannEpil Delivered to UK Patients		31/05/23	276.98KB	Share
RGT	Corporate Update - Board and UK Adviser Changes		30/05/23	213.92KB	Share
RGT	Notice of General Meeting/Proxy Form		30/05/23	451.38KB	Share
RGT	Distribution of General Meeting Documents - Notice of Access		30/05/23	240.39KB	Share
RGT	Change in Director's Interests x 5		05/05/23	817.3KB	Share

RGT RGT Commences Trading on the OTCQB Venture Market
07/05/24		177.59KB	Share
RGT Quarterly Activities/Appendix 4C Cash Flow Report
30/04/24	PRICE SENSITIVE	448.09KB	Share
RGT Notification regarding unquoted securities - RGT
26/04/24		16.8KB	Share
RGT Notification of cessation of securities - RGT
15/04/24		13.72KB	Share
RGT Argent BioPharma Appoints Dr Shlomo Sadoun to Advisory Board
15/04/24		156.12KB	Share
RGT Change of Company Name
02/04/24		190.13KB	Share
RGT s708A Cleansing Notice
28/03/24		216.29KB	Share
RGT Application for quotation of securities - MXC
28/03/24		15.72KB	Share
RGT Change of Director's Interest Notice - LM
28/03/24		178.63KB	Share
RGT Change of Director's Interest Notice - DR
28/03/24		174.6KB	Share
RGT Notification regarding unquoted securities - MXC
28/03/24		19.27KB	Share
RGT Refinancing of Convertible Security Agreement
28/03/24		225.34KB	Share
RGT Results of Meeting
18/03/24		465.62KB	Share
RGT Half Year Accounts
29/02/24	PRICE SENSITIVE	1.01MB	Share
RGT Notice of General Meeting/Proxy Form
13/02/24		837.82KB	Share
RGT Quarterly Activities/Appendix 4C Cash Flow Report
31/01/24	PRICE SENSITIVE	485.92KB	Share
RGT Notification regarding unquoted securities - MXC
19/01/24		25.15KB	Share
RGT s708A Cleansing Notice
10/01/24		215.49KB	Share
RGT Notification regarding unquoted securities - MXC
10/01/24		28.2KB	Share
RGT Notification regarding unquoted securities - MXC
10/01/24		23.77KB	Share
RGT Application for quotation of securities - MXC
10/01/24		24.85KB	Share
RGT Application for quotation of securities - MXC
10/01/24		25.73KB	Share
RGT Application for quotation of securities - MXC
10/01/24		25.27KB	Share
RGT Proposed issue of securities - MXC
22/12/23		28.25KB	Share
RGT Company Update & Capital Raising
22/12/23	PRICE SENSITIVE	252.55KB	Share
RGT Retraction of Statement
21/12/23	PRICE SENSITIVE	198.15KB	Share
RGT Pause in trading
21/12/23	PRICE SENSITIVE	116.81KB	Share
RGT ArtemiC Receives FDA Approval in Saudi Arabia
19/12/23		239.8KB	Share
RGT MGC Pharma Non-Deal Roadshow Presentation December 2023
18/12/23		2.63MB	Share
RGT s708A(5)(e) Cleansing Notice
01/12/23		219.35KB	Share
RGT Application for quotation of securities - MXC
01/12/23		28.96KB	Share
RGT Notification regarding unquoted securities - MXC
01/12/23		28.87KB	Share
RGT Initial Director's Interest Notice
01/12/23		195.37KB	Share
RGT Final Director's Interest Notice x 2
01/12/23		413.44KB	Share
RGT Corporate Update - Board and UK Adviser Changes
01/12/23		207.1KB	Share
RGT Results of Meeting
30/11/23		490.44KB	Share
RGT Change in substantial holding
09/11/23		24.76KB	Share
RGT Capital Consolidation and US$7.9m Placement Completed
08/11/23		215.15KB	Share
RGT s708A(5)(e) Cleansing Notice
07/11/23		219.19KB	Share
RGT Notification regarding unquoted securities - MXC
07/11/23		28.39KB	Share
RGT Application for quotation of securities - MXC
07/11/23		24.81KB	Share
RGT Proposed issue of securities - MXC
01/11/23		28.95KB	Share
RGT MGC Secures US$7.9 Million in Firm Commitments
01/11/23	PRICE SENSITIVE	270.27KB	Share
RGT Notice of Annual General Meeting/Proxy Form
31/10/23		1.09MB	Share
RGT Quarterly Activities/Appendix 4C Cash Flow Report
30/10/23	PRICE SENSITIVE	581.83KB	Share
RGT Trading Halt
30/10/23	PRICE SENSITIVE	581KB	Share
RGT Results of Meeting
25/10/23		485.05KB	Share
RGT Consolidation/Split - MXC
24/10/23		31.62KB	Share
RGT Annual General Meeting Update
09/10/23		199.6KB	Share
RGT Appendix 4G and Corporate Governance Statement
29/09/23		653.76KB	Share
RGT Annual Report to shareholders
29/09/23		3.14MB	Share
RGT Managing Director's Letter to Shareholders
26/09/23		249.08KB	Share
RGT Notice of General Meeting/Proxy Form
26/09/23		782.91KB	Share
RGT Change in substantial holding
08/09/23		53.13KB	Share
RGT s708A(5)(e) Cleansing Notice
06/09/23		218.72KB	Share
RGT Application for quotation of securities - MXC
06/09/23		25.61KB	Share
RGT Application for quotation of securities - MXC
06/09/23		25.22KB	Share
RGT Notification regarding unquoted securities - MXC
06/09/23		28.4KB	Share
RGT Results of Meeting
05/09/23		261.04KB	Share
RGT Change of Share Registry Address
01/09/23		202.3KB	Share
RGT Notification of cessation of securities - MXC
01/09/23		21.69KB	Share
RGT Application for quotation of securities - MXC
01/09/23		24.87KB	Share
RGT Preliminary Final Report
31/08/23	PRICE SENSITIVE	642.18KB	Share
RGT Share Purchase Plan Closed
30/08/23	PRICE SENSITIVE	227.06KB	Share
RGT Update - Proposed issue of securities - MXC
15/08/23		32.25KB	Share
RGT Extension of Share Purchase Plan Closing Date
15/08/23		210.23KB	Share
RGT Pre-clinical Trial Results on CimetrA
14/08/23	PRICE SENSITIVE	279.17KB	Share
RGT Notice of General Meeting/Proxy Form
04/08/23		882.63KB	Share
RGT Prospectus and Share Purchase Plan Documents
03/08/23		631.1KB	Share
RGT Company Update
02/08/23		210.1KB	Share
RGT Proposed issue of securities - MXC
01/08/23		32.63KB	Share
RGT MGC Pharma Launches Share Purchase Plan
01/08/23	PRICE SENSITIVE	218.64KB	Share
RGT MGC receives permission for first import of Psilocybin
31/07/23	PRICE SENSITIVE	256.18KB	Share
RGT Resignation of Joint Company Secretary
28/07/23		206.96KB	Share
RGT Quarterly Activities/Appendix 4C Cash Flow Report
28/07/23	PRICE SENSITIVE	782.69KB	Share
RGT Clarification Announcement
21/07/23		252.3KB	Share
RGT Change in substantial holding
19/07/23		183.92KB	Share
RGT s708A(5)(e) Cleansing Notice
14/07/23		275.41KB	Share
RGT Notification regarding unquoted securities - MXC
14/07/23		29.13KB	Share
RGT Application for quotation of securities - MXC
14/07/23		26.78KB	Share
RGT Update - Proposed issue of securities - MXC
14/07/23		29.25KB	Share
RGT Proposed issue of securities - MXC
14/07/23		24.95KB	Share
RGT Proposed issue of securities - MXC
14/07/23		29.44KB	Share
RGT Commitments Received for GBP 0.7m
14/07/23	PRICE SENSITIVE	482.3KB	Share
RGT Clarification Announcement
12/07/23		218.93KB	Share
RGT AMC Places Second Order of ArtemiC for US$1M
07/07/23	PRICE SENSITIVE	242.11KB	Share
RGT MGC Welcomes Reclassification of Psychedelic Compounds
03/07/23		194.7KB	Share
RGT Details of Company Address
30/06/23		222.41KB	Share
RGT Company Update
30/06/23		208.34KB	Share
RGT Results of Meeting
29/06/23		464.39KB	Share
RGT s708A(5)(e) Cleansing Notice
21/06/23		228.64KB	Share
RGT Application for quotation of securities - MXC
21/06/23		25.09KB	Share
RGT Final Director's Interest Notice x 2
01/06/23		432.88KB	Share
RGT Initial Director's Interest Notice
01/06/23		198.4KB	Share
RGT Appointment of Non-Executive Director
01/06/23		211.57KB	Share
RGT First CannEpil Delivered to UK Patients
31/05/23		276.98KB	Share
RGT Corporate Update - Board and UK Adviser Changes
30/05/23		213.92KB	Share
RGT Notice of General Meeting/Proxy Form
30/05/23		451.38KB	Share
RGT Distribution of General Meeting Documents - Notice of Access
30/05/23		240.39KB	Share
RGT Change in Director's Interests x 5
05/05/23		817.3KB	Share

REFRESH

1 2 3 4 5 6

(20min delay)
Last 37.5¢		Change 0.000(0.00%)		Mkt cap ! $16.98M

Open	High	Low	Value	Volume
37.5¢	37.5¢	37.5¢	$662	1.765K

Buyers (Bids)

No.	Vol.	Price($)
3	1195	37.5¢

Sellers (Offers)

Price($)	Vol.	No.
39.5¢	163	1

View Market Depth

No.	Vol.	Price($)
3	1195	0.375
1	604	0.370
1	10000	0.365
1	8500	0.360
3	7455	0.350

Price($)	Vol.	No.
0.395	163	1
0.400	2550	2
0.410	5000	1
0.420	460	1
0.430	3323	2

Last trade - 14.47pm 22/05/2024 (20 minute delay)

RGT (ASX) Chart

ARGENT BIOPHARMA LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories